How Do You Spell ACLARUBICIN?

Pronunciation: [ɐklˈɑːɹuːbˌɪsɪn] (IPA)

The word "Aclarubicin" is commonly used in the medical field as a chemotherapeutic agent. Its spelling can be explained using the International Phonetic Alphabet (IPA) as əˌklærjuːˈbaɪsɪn. The first syllable, "acla," is pronounced with a schwa sound followed by a clear /l/ and unstressed second syllable "-ru." The third syllable is pronounced with a long "oo" /u:/ sound, and the final syllable "-sin" is pronounced with a clear /s/ sound. The phonetic transcription helps us understand the spelling, and also helps in correct pronunciation.

ACLARUBICIN Meaning and Definition

1. Aclarubicin is a noun that refers to an antibiotic and anticancer drug belonging to the anthracycline class. It is derived from the natural product daunorubicin and is primarily used in the treatment of certain types of cancer, including acute myeloid leukemia and solid tumors. Aclarubicin exerts its pharmacological effects by inhibiting DNA and RNA synthesis, thus disrupting the growth and division of cancer cells.

   This medication is usually administered intravenously under medical supervision due to its potent activity and potential side effects. It is commonly given in combination with other chemotherapy drugs as part of a comprehensive treatment regimen. Aclarubicin is known to have a relatively rapid and high penetration into tumor tissues, making it an effective agent against certain malignancies.

   However, like other anthracyclines, aclarubicin is associated with various adverse effects. Some of the commonly reported side effects include bone marrow suppression, leading to decreased blood cell counts, increased susceptibility to infections, and anemia. It can also cause gastrointestinal disturbances such as nausea, vomiting, and diarrhea. Additionally, aclarubicin may have potential cardiotoxic effects, leading to cardiomyopathy and heart failure.

   In conclusion, aclarubicin is a potent antibiotic and anticancer drug used in the treatment of specific types of cancer. Its mechanism of action involves inhibiting DNA and RNA synthesis to halt cancer cell proliferation. Although it offers therapeutic benefits, its notable side effects necessitate careful monitoring and management during treatment.

Common Misspellings for ACLARUBICIN

• zclarubicin
• sclarubicin
• wclarubicin
• qclarubicin
• axlarubicin
• avlarubicin
• aflarubicin
• adlarubicin
• ackarubicin
• acparubicin
• acoarubicin
• aclzrubicin
• aclsrubicin
• aclwrubicin
• aclqrubicin
• aclaeubicin
• acladubicin
• aclafubicin
• aclatubicin
• acla5ubicin

Etymology of ACLARUBICIN

The word "Aclarubicin" has a relatively straightforward etymology. It is derived from the combination of two elements: "aclari-" and "-rubicin".

The prefix "aclari-" is believed to be influenced by the term "chlarificare", which is Latin for "to clarify" or "to make clear". This prefix suggests the drug's ability to clear or remove certain substances or conditions.

The suffix "-rubicin" is commonly used in the naming of various antibiotics and anticancer drugs. It is derived from "rubeus", which means red in Latin. This suffix refers to the red color of certain compounds or their ability to produce a reddish color.

Combining these elements, "Aclarubicin" essentially implies a drug that helps to clarify or remove certain substances or conditions and possesses a red color or reddish properties.